Wells Fargo’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $150K | Buy |
|
|||||
|
2024
Q3 | $201K | Sell |
|
|||||
|
2024
Q2 | $162K | Buy |
|
|||||
|
2024
Q1 | $271K | Buy |
|
|||||
|
2023
Q4 | $336K | Buy |
|
|||||
|
2023
Q3 | $405K | Sell |
|
|||||
|
2023
Q2 | $1.82M | Buy |
|
|||||
|
2023
Q1 | $1.74M | Sell |
|
|||||
|
2022
Q4 | $1.56M | Sell |
|
|||||
|
2022
Q3 | $2.5M | Buy |
|
|||||
|
2022
Q2 | $1.28M | Sell |
|
|||||
|
2022
Q1 | $2.02M | Sell |
|
|||||
|
2021
Q4 | $2.78M | Sell |
|
|||||
|
2021
Q3 | $13.7M | Buy |
|
|||||
|
2021
Q2 | $12.1M | Sell |
|
|||||
|
2021
Q1 | $11.8M | Sell |
|
|||||
|
2020
Q4 | $12.2M | Buy |
|
|||||
|
2020
Q3 | $6.33M | Buy |
|
|||||
|
2020
Q2 | $1.9M | Buy |
|
|||||
|
2020
Q1 | $837K | Buy |
|
|||||
|
2019
Q4 | $728K | Buy |
|
|||||
|
2019
Q3 | $369K | Buy |
|
|||||
|
2019
Q2 | $346K | Buy |
|
|||||
|
2019
Q1 | $313K | Buy |
|
|||||
|
2018
Q4 | $366K | Buy |
|
|||||
|
2018
Q3 | $390K | Buy |
|
|||||
|
2018
Q2 | $398K | Sell |
|
|||||
|
2018
Q1 | $789K | Buy |
|
|||||
|
2017
Q4 | $499K | Sell |
|
|||||
|
2017
Q3 | $522K | Sell |
|
|||||
|
2017
Q2 | $615K | Sell |
|
|||||
|
2017
Q1 | $1.48M | Sell |
|
|||||
|
2016
Q4 | $1.78M | Buy |
|
|||||
|
2016
Q3 | $178K | Buy |
|
|||||
|
2016
Q2 | $126K | Sell |
|
|||||
|
2016
Q1 | $184K | Buy |
|
|||||
|
2015
Q4 | $253K | Sell |
|
|||||
|
2015
Q3 | $261K | Buy |
|
|||||
|
2015
Q2 | $234K | Buy |
|
|||||
|
2015
Q1 | $97K | Buy |
|
|||||
|
2014
Q4 | $32K | Buy |
|
|||||
|
2014
Q3 | $36K | Buy |
|
|||||
|
2014
Q2 | $39K | Buy |
|